Cardiff Oncology
CA - San DiegoBiotechnology
Focus: Cardiff Oncology is a San Diego-based biotechnology company focused on developing cancer therapies, with a pipeline concentrated on the Onvansertib program across multiple oncology indications.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Cardiff Oncology
AI assessmentNot HiringNo open roles listed right now. Follow Cardiff Oncology to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
14 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Onvansertib
Metastatic Colorectal CancerClinical Trials (1)
NCT04446793Expanded Access of Onvansertib With FOLFIRI and Bevacizumab for the Second-Line Treatment of Participants With KRAS-Mutated Metastatic Colorectal Cancer
N/AHelp build intelligence for Cardiff Oncology
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.